IL305931A - Pyrazolopyridine derivatives and their uses - Google Patents

Pyrazolopyridine derivatives and their uses

Info

Publication number
IL305931A
IL305931A IL305931A IL30593123A IL305931A IL 305931 A IL305931 A IL 305931A IL 305931 A IL305931 A IL 305931A IL 30593123 A IL30593123 A IL 30593123A IL 305931 A IL305931 A IL 305931A
Authority
IL
Israel
Prior art keywords
pyrazolopyridine derivatives
pyrazolopyridine
derivatives
Prior art date
Application number
IL305931A
Other languages
English (en)
Hebrew (he)
Inventor
Simone Bonazzi
Artiom Cernijenko
Jennifer Stroka Cobb
Natalie Alysia Dales
Janetta Dewhurst
Matthew James Hesse
Rama Jain
John Ryan Kerrigan
Hasnain Ahmed Malik
James R Manning
Gary O'brien
Andrew W Patterson
Noel Marie-France Thomsen
Pamela Yf Ting
Original Assignee
Novartis Ag
Simone Bonazzi
Artiom Cernijenko
Jennifer Stroka Cobb
Natalie Alysia Dales
Janetta Dewhurst
Matthew James Hesse
Rama Jain
John Ryan Kerrigan
Hasnain Ahmed Malik
James R Manning
Obrien Gary
Andrew W Patterson
Thomsen Noel Marie France
Pamela Yf Ting
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Simone Bonazzi, Artiom Cernijenko, Jennifer Stroka Cobb, Natalie Alysia Dales, Janetta Dewhurst, Matthew James Hesse, Rama Jain, John Ryan Kerrigan, Hasnain Ahmed Malik, James R Manning, Obrien Gary, Andrew W Patterson, Thomsen Noel Marie France, Pamela Yf Ting filed Critical Novartis Ag
Publication of IL305931A publication Critical patent/IL305931A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL305931A 2021-03-15 2022-03-14 Pyrazolopyridine derivatives and their uses IL305931A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163161139P 2021-03-15 2021-03-15
US202163164130P 2021-03-22 2021-03-22
PCT/IB2022/052281 WO2022195454A1 (en) 2021-03-15 2022-03-14 Pyrazolopyridine derivatives and uses thereof

Publications (1)

Publication Number Publication Date
IL305931A true IL305931A (en) 2023-11-01

Family

ID=80819999

Family Applications (1)

Application Number Title Priority Date Filing Date
IL305931A IL305931A (en) 2021-03-15 2022-03-14 Pyrazolopyridine derivatives and their uses

Country Status (20)

Country Link
US (4) US11787785B2 (cg-RX-API-DMAC7.html)
EP (1) EP4308562A1 (cg-RX-API-DMAC7.html)
JP (2) JP7659648B2 (cg-RX-API-DMAC7.html)
KR (1) KR102902295B1 (cg-RX-API-DMAC7.html)
AU (2) AU2022239950B2 (cg-RX-API-DMAC7.html)
CA (1) CA3208951A1 (cg-RX-API-DMAC7.html)
CL (1) CL2023002726A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023013486A2 (cg-RX-API-DMAC7.html)
CR (1) CR20230486A (cg-RX-API-DMAC7.html)
DO (1) DOP2023000188A (cg-RX-API-DMAC7.html)
EC (1) ECSP23076800A (cg-RX-API-DMAC7.html)
IL (1) IL305931A (cg-RX-API-DMAC7.html)
JO (1) JOP20230218A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023010827A (cg-RX-API-DMAC7.html)
PE (1) PE20242203A1 (cg-RX-API-DMAC7.html)
PY (1) PY2217419A (cg-RX-API-DMAC7.html)
TW (1) TWI923713B (cg-RX-API-DMAC7.html)
UY (1) UY39671A (cg-RX-API-DMAC7.html)
WO (1) WO2022195454A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202307290B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021255160B2 (en) 2020-04-13 2024-02-01 Aptabio Therapeutics Inc. Pulmonary fibrosis medicine containing pyrazole derivative
EP4308559A1 (en) * 2021-03-15 2024-01-24 Novartis AG Benzisoxazole derivatives and uses thereof
UY39671A (es) 2021-03-15 2022-10-31 Novartis Ag Derivados de pirazolopiridina y sus usos.
PE20240822A1 (es) 2021-03-22 2024-04-18 Neurocrine Biosciences Inc Inhibidores de vmat2 y metodos de uso
CN120129677A (zh) 2022-11-04 2025-06-10 百时美施贵宝公司 化合物及其用于治疗血红素病变的用途
WO2024255810A1 (en) * 2023-06-15 2024-12-19 Hangzhou Glubio Pharmaceutical Co., Ltd Dihydropyrimidine-2, 4 (1h, 3h) -dione-containing polycyclic derivatives and pharmaceutical composition thereof, preparation method thereof and use thereof
WO2026136866A1 (en) 2024-12-20 2026-06-25 Prelude Therapeutics Incorporated Kat6 targeting compounds

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004078163A2 (en) 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
BRPI0417186A (pt) 2003-12-02 2007-03-06 Celgene Corp método de tratamento de um indivìduo tendo uma hemoglobinopatia ou uma anemia, de modulação da diferenciação de uma célula-tronco ou precursora de cd34+ para uma linhagem de eritróides, e, composição farmacêutica
EP1604988A1 (en) 2004-05-18 2005-12-14 Sanofi-Aventis Deutschland GmbH Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
CN102089291B (zh) 2008-04-28 2016-08-17 杏林制药株式会社 环戊基丙烯酰胺衍生物
EP2165707A1 (en) * 2008-09-23 2010-03-24 Genkyo Tex Sa Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
SG183257A1 (en) 2010-02-11 2012-09-27 Celgene Corp Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
ES2689429T3 (es) 2012-07-13 2018-11-14 Ucb Biopharma Sprl Derivados de imidazopiridina como moduladores de actividad de TNF
US9845308B2 (en) 2014-11-05 2017-12-19 Vitae Pharmaceuticals, Inc. Isoindoline inhibitors of ROR-gamma
TWI793151B (zh) * 2017-08-23 2023-02-21 瑞士商諾華公司 3-(1-氧異吲哚啉-2-基)之氫吡啶-2,6-二酮衍生物及其用途
US11512080B2 (en) 2018-01-12 2022-11-29 Kymera Therapeutics, Inc. CRBN ligands and uses thereof
JP2020009513A (ja) * 2018-07-10 2020-01-16 キオクシア株式会社 メモリシステム
AR116109A1 (es) * 2018-07-10 2021-03-31 Novartis Ag Derivados de 3-(5-amino-1-oxoisoindolin-2-il)piperidina-2,6-diona y usos de los mismos
EP3897631A4 (en) 2018-12-20 2022-11-23 C4 Therapeutics, Inc. TARGETED PROTEIN BREAKDOWN
KR102980990B1 (ko) 2019-04-05 2026-06-25 카이메라 쎄라퓨틱스 인코포레이티드 Stat 분해제 및 이의 용도
EP3969458A4 (en) 2019-05-13 2023-05-17 Borah, Inc. CHEMICAL COMPOUNDS
PH12022551482A1 (en) 2019-12-18 2023-11-29 Novartis Ag 3-(5-methoxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
EP4100394B1 (en) 2020-02-04 2026-04-08 Stingray Therapeutics, Inc. Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (enpp1) and methods of use thereof
US20230089530A1 (en) 2020-02-09 2023-03-23 Newave Pharmaceutical Inc. Quinuclidinone analogues as anticancer agents
UY39671A (es) 2021-03-15 2022-10-31 Novartis Ag Derivados de pirazolopiridina y sus usos.

Also Published As

Publication number Publication date
PE20242203A1 (es) 2024-11-19
ZA202307290B (en) 2024-09-25
JP7659648B2 (ja) 2025-04-09
TW202304900A (zh) 2023-02-01
AU2022239950B2 (en) 2024-09-12
AU2022239950A1 (en) 2023-08-31
MX2023010827A (es) 2023-09-28
CL2023002726A1 (es) 2024-04-01
BR112023018542A2 (pt) 2023-10-10
EP4308562A1 (en) 2024-01-24
US20250282762A1 (en) 2025-09-11
JP2024509981A (ja) 2024-03-05
AU2024278210A1 (en) 2025-01-02
UY39671A (es) 2022-10-31
CA3208951A1 (en) 2022-09-22
AU2024278210B2 (en) 2026-03-26
DOP2023000188A (es) 2023-11-15
PY2217419A (es) 2022-09-27
WO2022195454A1 (en) 2022-09-22
NZ802195A (en) 2025-10-31
JOP20230218A1 (ar) 2023-09-14
ECSP23076800A (es) 2023-11-30
KR102902295B1 (ko) 2025-12-23
US20250002479A1 (en) 2025-01-02
US20240158374A1 (en) 2024-05-16
US12172984B2 (en) 2024-12-24
CO2023013486A2 (es) 2023-11-10
KR20230156766A (ko) 2023-11-14
US11787785B2 (en) 2023-10-17
US12252482B2 (en) 2025-03-18
US20230108325A1 (en) 2023-04-06
TWI923713B (zh) 2026-05-01
CR20230486A (es) 2024-01-25
JP2025106341A (ja) 2025-07-15

Similar Documents

Publication Publication Date Title
SG11201912267SA (en) Nicotinamide riboside derivatives and their uses
PL3786160T3 (pl) Pochodne pirydyny i ich zastosowania terapeutyczne jako inhibitory trpc6
EP4037670A4 (en) 5-FLUORONICOTINAMIDE DERIVATIVES AND USES THEREOF
PL3615035T3 (pl) Zastosowanie 20-hydroksyekdyzonu i jego pochodnych w leczeniu miopatii
IL300577B1 (en) Novel dioxoloisoquinolinone derivatives and use thereof
GB202002010D0 (en) Microtopographies and uses thereof
GB2606804B (en) Benzenesulfonamide derivatives and uses thereof
EP4276099A4 (en) PYRIDONE DERIVATIVES WITH MULTIPLE RINGS AND THEIR USE
EP3845527A4 (en) MULTISUBSTITUTED PYRIDONE DERIVATIVES AND THEIR MEDICAL USE
GB201711234D0 (en) Pyrrolopyrimidine and pyrrolopyridine derivatives
PL4011898T3 (pl) Pochodna 3-hydroksy-5-pregnan-20-onu i jej zastosowanie
GB202307610D0 (en) Benzenesulfonamide derivatives and uses thereof
IL282527A (en) 5-Azaindazole history and their use
IL299732A (en) Macrocycles and their use
PT3983387T (pt) Derivados de sulfonilurea e seus usos
IL274722A (en) History of pyridinones and their use as selective inhibitors of ALK-2
SG11202008543RA (en) Pyrrolidineamide derivatives and uses thereof
IL282526A (en) 5-Azaindazole history and their use
IL261645A (en) History of dioxo-hexahydroisoindolyl and their use as cyclophilin inhibitors
EP4201405A4 (en) PYRROLOPYRIDINE DERIVATIVE AND USE THEREOF
GB202103872D0 (en) Uses and methods
IL274868A (en) History of imidazopyridine and their use as medicine
EP4028502A4 (en) N-ACYL-TYROSINE DERIVATIVES AND THEIR USE
HUE069942T2 (hu) Klorotoxin-származékok és alkalmazásuk
HK40098158A (en) Pyrazolopyridine derivatives and uses thereof